Amryt Pharma (LON:AMYT) has been reiterated to Speculative Buy in a statement by Beaufort Securities earlier today.
- Updated: September 19, 2016
Only yesterday Amryt Pharma (LON:AMYT) traded 3.77% lower at 19.50GBX. Amryt Pharma’s 50-day average is 18.84GBX and its two hundred day moving average is 19.06GBX. The last stock price close is up 2.83% from the two hundred day moving average, compared with the S&P 500 which has fallen -0.01% over the same time. 1,340 shares of Amryt Pharma traded hands, down from ann avg. trading volume of 164,873.
Beaufort Securities has reiterated Amryt Pharma(LON:AMYT) to Speculative Buy in a report released 9/20/2016.
Recent Performance Graph:
In addition to Beaufort Securities reporting it’s stock price target, a total of 1 analysts has issued a report on the stock. The one year target price is 42.06GBX with 0 rating the stock a strong buy, 0 rating the stock a buy, 0 firms rating the stock a hold, 0 rating the company to underperform, and finally 0 brokerages rating the stock as sell.
With a total market value of 0.0 GBX, Amryt Pharma has a one-year low of 14.00GBX and a one-year high of 31.20GBX with a P/E ratio of 0.
Brief Synopsis About Amryt Pharma (LON:AMYT)
Amryt Pharma plc, formerly Fastnet Equity plc, is a United Kingdom-based specialty pharmaceutical company. The Company focuses on developing and delivering treatments for patients with rare and orphan diseases. The Company’s products include Episalvan and Imlan. The Company’s products focus on developing somatostatin analogue (SSA) peptide medicines for patients with rare neuroendocrine diseases, including acromegaly and Cushing’s disease. The Company’s Episalvan is a prescription pharmaceutical product, which accelerates wound healing. The Company’s Episalvan consists of two ingredients, such as betulin-based active ingredient and sunflower oil as the excipient. The Company’s Imlan products have regenerative and anti-inflammatory properties. Betulin is the active ingredient in the Imlan products and functions as the stabilizer of the creams and lotions. The Company’s Imlan Creme Pur consists of Betulin, and oil and water ingredients.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.